Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Today's Top SOA Links


Coyote Pharmaceuticals to Present at Biotech Showcase™ 2013

MENLO PARK, Calif., Jan. 2, 2013 /PRNewswire/ -- Coyote Pharmaceuticals, Inc., an emerging biopharmaceutical company focused on neurodegenerative diseases, announced today that President and CEO, Hiroaki Serizawa, Ph.D. will present at the Biotech Showcase™ 2013 Conference being held in San Francisco January 7-9, 2013.  Dr. Serizawa will provide an overview of the company's lead compound, CNS-102, which will soon enter clinical development for amyotrophic lateral sclerosis (ALS) and Alzheimer's disease (AD).

Details of Coyote's presentation are as follows:

Event:


Biotech Showcase 2013 Conference

Date: 


Wednesday, January 9, 2013

Time: 


2:45 pm PST

Location:


Parc 55 Wyndham San Francisco Union Square Hotel

Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present and meet with investors and pharmaceutical executives during the course of one of the industry's largest annual healthcare investor conferences.  Investors and biopharmaceutical executives from around the world gather in San Francisco during this critical week, which is widely viewed as setting the tone for the coming year.

About Coyote Pharmaceuticals:

Coyote Pharmaceuticals, Inc. is an emerging biopharmaceutical company focused on treating neurodegenerative diseases through the modulation of protein folding and transport vital to maintaining cellular homeostasis.  The company's lead drug candidate, CNS-102, is being developed initially to treat amyotrophic lateral sclerosis (ALS) and Alzheimer's disease (AD).  The orally bioavailable small molecule therapeutic is designed to activate gene expression of a family of proteins – known as heat shock proteins – involved in regulating the folding and transport of other proteins. Heat shock proteins are capable of preventing and repairing the pathophysiological aggregation of other cellular proteins, which are implicated in the etiology of ALS and AD.  For more information on Coyote visit http://www.coyotepharma.com.

For Media & Investors:
Jason Rando / Joshua Drumm, Ph.D.
Tiberend Strategic Advisors, Inc.
(212) 827-0020
jrando@tiberend.com
jdrumm@tiberend.com

 

SOURCE Coyote Pharmaceuticals, Inc.

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Web 2.0 Latest News
The start of a new year is always a good time for many businesses to get their IT strategies in place. However, there has been one issue in the past couple of months that may potentially cause a lot of complications in IT departments across the US and EU; the implications for cloud com...
Microsoft pulls a fast one! Good showing Microsoft. Project Natick is Microsoft's R&D feasibility project to explore, manufacture and operate a underwater. Hey, you don't look for cooling water, if you can take the salt out. How is latency improved? drop the datacenter at the neare...
The Net Neutrality fight has been all over the news this year with the latest installment on Net Neutrality coming in from T-Mobile. Private and public companies alike are tuned into to this continual saga to see how the eventual outcome will affect business and ultimately their online...
Over the years, one of my favorite pastimes has been working on the family genealogy. I first started work on it in the early 1990s. At that time, records were not digitized and research involved going to libraries, newspapers, and various local, state, and federal archives. There one ...
I often write about the Internet of Things, or the soon-to-be-cliché IoT. You know, the smart-fridges, smart-cars, smart-thermostats, healthcare devices, wearables and any of those connected devices that have a sensor, gathers data and reports back to some entity. You are able to contr...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE